Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,334,208
-$194,765 QoQ
Shares Held
9,276
-20.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.04%
of 13F equity value
Holder Rank
#1,850
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aberdeen Wealth Management LLC holds $7,869,904 across 14 Drug Manufacturers - General names. ABBV ranks #1 (29.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
9,276 | $2,334,208 | |
| 2 | JNJ |
Johnson & Johnson
|
8,486 | $2,155,180 | |
| 3 | NVS |
Novartis AG
|
6,045 | $947,369 | |
| 4 | AMGN |
Amgen Inc
|
1,542 | $558,386 | |
| 5 | LLY |
ELI LILLY & Co
|
370 | $443,788 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,329 | $307,055 | |
| 7 | PFE |
Pfizer Inc
|
12,072 | $290,687 | |
| 8 | NVO |
Novo Nordisk A S
|
4,946 | $237,111 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,334,208 | 9,276 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,528,973 | 11,628 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,668,306 | 11,678 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,779,174 | 12,003 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,227,996 | 12,003 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,585,267 | 12,339 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $2,209,877 | 12,436 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $2,566,252 | 12,995 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,571,427 | 14,992 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,720,391 | 14,939 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,082,176 | 13,436 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,233,365 | 14,983 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,018,255 | 14,980 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,386,884 | 14,977 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,436,109 | 15,074 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,285,730 | 17,031 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,608,008 | 17,028 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,759,922 | 17,025 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,304,778 | 17,022 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,835,839 | 17,019 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,949,911 | 17,311 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $1,873,071 | 17,308 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,899,555 | 17,728 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,516,007 | 17,308 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,698,906 | 17,304 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,314,125 | 17,248 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||